Defending two dilemmas.
| Autor: | Baron T; Interdisciplinary Research Lab for Bioethics, Institute of Philosophy, Czech Academy of Sciences, Praha, Czech Republic baron@flu.cas.cz.; Institut für die Wissenschaften vom Menschen, Wien, Austria., Dierckxsens G; Interdisciplinary Research Lab for Bioethics, Institute of Philosophy, Czech Academy of Sciences, Praha, Czech Republic. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of medical ethics [J Med Ethics] 2022 Sep; Vol. 48 (9), pp. 639-640. Date of Electronic Publication: 2021 Oct 05. |
| DOI: | 10.1136/medethics-2021-107856 |
| Abstrakt: | Ashley's response to our recent paper argues that a fuller appreciation of the available clinical data, of the rights of children to autonomy, and of the primary purpose of gender-affirming endocrine treatment supports the rejection of both the pathway and consent dilemmas for the treatment of gender dysphoria, as raised in this journal. In this response, we highlight certain misrepresentations of our argument, and defend our conclusions against Ashley's main objections. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|